A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer

By              

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 855-859

Spandidos Publications

Access to resources Recommend Favorite

Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer

By                              

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 15-21

Spandidos Publications

Access to resources Recommend Favorite

Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

By Recio F.O.   Piver M.S.   Hempling R.E.   Driscoll D.L.  

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite

Cisplatin-based Chemotherapy in Advanced Seminoma: the Institut Gustave Roussy Experience

By Culine S.   Abs L.   Terrier-Lacombe M.J.   Theodore C.   Wibault P.   Droz J.-P.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 353-358

Elsevier

Access to resources Recommend Favorite

Clostridium difficile Colitis Associated with Cisplatin-Based Chemotherapy in Ovarian Cancer Patients

By Emoto M.   Kawarabayashi T.   Hachisuga T.   Eguchi F.   Shirakawa K.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 369-372

Academic Press

Access to resources Recommend Favorite